With the goals of promoting interdisciplinary integration and sharing of clinical practical experience, facilitating the translation of the latest research findings into practice, enhancing healthcare professionals' comprehensive management capabilities for comorbidities, optimizing clinical pathways, and ultimately contributing professional expertise to improving patients' quality of life and alleviating the societal burden of disease, the "Series Symposium on Hyperlipidemia, Hyperglycemia, and Hypertension from a Population-Wide Perspective: Management and Challenges of Comorbidities (11th Session)", hosted by the Chengdu High-Tech Medical Association, was successfully conducted online on July 26, 2025.

This conference focused on the increasingly prominent public health challenge of "triple high" comorbidities, exploring in depth their pathogenesis, management strategies, and innovations in prevention and control models from a holistic, population-wide health perspective. It aimed to establish a high-level, forward-looking academic exchange platform to continuously drive innovation and practice in the field of chronic disease prevention and control in China.